SCHEMBL26159296

SCHEMBL26159296

c1c2c(cc3c1OCCO3)-c1cc3ccc4c(c3c[n+]1CC2)OCCO4

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.82
METTL3 Q86U44 1/20 0.80
METTL14 Q9HCE5 1/20 0.80
ALDH1A1 P00352 3/20 0.62
LMNA P02545 3/20 0.62
MAPT P10636 3/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
MEN1 O00255 2/20 0.62
KDM1A O60341 2/20 0.62
KMT2A Q03164 2/20 0.62
KDM4E B2RXH2 1/20 0.62
POLB P06746 1/20 0.62
HPGD P15428 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
SAE1 Q9UBE0 1/20 0.62
UBA2 Q9UBT2 1/20 0.62
ACHE P22303 9/20 0.56
BCHE P06276 7/20 0.56
EP300 Q09472 3/20 0.56
CYP3A4 P08684 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Coptisine SCHEMBL156866 0.90 IDO1 (1.00) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL29931632 0.90 IDO1 (1.00) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL31392604 0.90 IDO1 (1.00) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL154528 0.89 METTL3 (1.00) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL2441815 0.89 IDO1 (0.98) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL8858972 0.84 IDO1 (0.87) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL158088 0.81 METTL3 (0.82) IDO1METTL3METTL14ALDH1A1LMNA
SCHEMBL26159291 0.80 IDO1 (0.55) IDO1METTL3METTL14ALDH1A1LMNA
SCHEMBL25931816 0.79 EP300 (0.88) IDO1ALDH1A1LMNAMAPTSMN1; SMN2
Coptisine SCHEMBL16279007 0.79 METTL3 (0.79) IDO1METTL3METTL14ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023088319-A1 MONTELUKAST BERBERINE QUATERNARY AMMONIUM SALT COMPOUND AND DOUBLE SALT COMPOSITION, AND SYNTHESIS METHOD THEREFOR AND USE THEREOF 温州医科大学附属眼视光医院 2023-05-25 WO disclosed